-------------------------------------------------------------------------
Balance, June 30,
2007 21,230,741 133,988,318 4,487,752 1,538,396
-------------------------------------------------------------------------
-------------------------------------------------------------------------
For the years ended June 30, 2007 and 2006
(in Canadian dollars)
Share-
Exchange Total holders'
Warrants Rights Deficit Equity
-------------------------------------------------------------------------
$ $ $
Balance, July 1, 2005 486,615 388,000 (46,486,090) 35,198,470
Share issued for
purchased assets of
Protana, net - - - 1,184,569
Issued pursuant to
bought deal
financing, net - - - 9,648,600
Issued on exercise of
Exchange Rights - (145,500) - 863,937
Exchange Rights
expired unexercised - (242,500) - -
Expiry of share
purchase warrants (486,615) - - -
Issued on acquisition
of ENI, net - - - 10,727,317
Issued to acquire
patent portfolio - - - 286,000
Cancellation of shares
issued to ENI - - - -
Stock options exercised - - - 8,016
Stock options expired - - - -
Stock-base
'/>"/>
| SOURCE Transition Therapeutics Inc. Copyright©2007 PR Newswire. All rights reserved |